This announcement is a separate document:
國藥科技股份：根據第二份認購協議發行可換股債券之失效
SINOPHARM TECH: LAPSE OF THE ISSUE OF CONVERTIBLE BONDS UNDER THE SECOND SUBSCRIPTION AGREEMENT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.